Lab-on-a-Chip and CRISPR-Cas - A Synergistic Approach to Advancing Molecular Diagnostics

Explore the powerful combination of CRISPR-Cas technology and Lab-on-a-Chip (LOC) systems in this 23-minute webinar presented by postdoctoral researcher Nienke van Dongen from the University of Twente's BIOS Lab on a Chip group. Discover how CRISPR-Cas systems, originally developed for gene editing, have evolved into sophisticated molecular diagnostic tools and learn why traditional biochemical methods like real-time PCR and plate readers face limitations in sensitivity, speed, and usability. Examine the synergistic relationship between CRISPR-Cas diagnostics and microfluidic technology, understanding how their integration significantly improves detection limits, enhances usability, and increases accessibility for clinical applications. Investigate the advantages of LOC technology, including miniaturization, automation, and integration capabilities that enable more efficient CRISPR-based diagnostics with greater sensitivity using minimal sample volumes. Learn about cutting-edge research developments in microfluidic platforms specifically designed for early cancer detection, focusing on how these technologies can revolutionize cancer biomarker detection in liquid biopsies. Understand the potential for point-of-care applications and more accessible diagnostics in cancer care, with insights into creating highly sensitive, rapid, and portable diagnostic tools that could transform patient outcomes. Gain knowledge about the technical challenges and solutions in combining these technologies, supported by real-world examples from ongoing research and patent applications in the field of CRISPR diagnostics.